MirZyme Therapeutics
PrivateLast Round
Series A
Apr 21, 2025
Total Funding Raised
$910,000
Company Overview
MirZyme Therapeutics is a biopharmaceutical company that develops laboratory-based diagnostic assays and orally administered therapeutic compounds to prevent preeclampsia and fetal growth restriction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MirZyme Therapeutics Comparables
Compare MirZyme Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Comanche Biopharma | 86% | |
| Trinity Biotech plc | 77% | |
| Corion Biotech | 76% | |
MirZyme Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 21, 2025 | ||||
| Accelerator | Aug 21, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Nov 1, 2023 |
Key People
Founding team and executive leadership
MirZyme Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2026
Monthly visitors grew 136% MoM.
- Oct 30, 2024
Monthly visitors increased 60% MoM.
MirZyme Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MirZyme Therapeutics's valuation, stock price, and market status.